X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
medical and health sciences (71) 71
medicin och hälsovetenskap (71) 71
clinical medicine (50) 50
klinisk medicin (50) 50
humans (46) 46
hematology (38) 38
pediatrics (37) 37
child (36) 36
female (32) 32
male (32) 32
child, preschool (30) 30
infant (30) 30
pediatrik (29) 29
adolescent (27) 27
cancer and oncology (25) 25
cancer och onkologi (25) 25
hematologi (22) 22
children (21) 21
index medicus (20) 20
oncology (18) 18
medical genetics (16) 16
leukemia (15) 15
childhood (14) 14
medicinsk genetik (14) 14
basic medicine (13) 13
medicinska och farmaceutiska grundvetenskaper (13) 13
precursor cell lymphoblastic leukemia-lymphoma - genetics (13) 13
cancer (11) 11
infant, newborn (10) 10
prognosis (10) 10
acute myeloid leukaemia (9) 9
acute myeloid-leukemia (9) 9
medicine (9) 9
acute lymphoblastic-leukemia (8) 8
acute lymphocytic leukemia (8) 8
medicin (8) 8
methotrexate (8) 8
acute disease (7) 7
chemotherapy (7) 7
disease-free survival (7) 7
follow-up studies (7) 7
genetics & heredity (7) 7
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (7) 7
survival (7) 7
survival analysis (7) 7
acute lymphoblastic leukemia (6) 6
gene expression profiling (6) 6
leukemia, myeloid, acute - genetics (6) 6
methotrexate - administration & dosage (6) 6
precursor cell lymphoblastic leukemia-lymphoma - pathology (6) 6
recurrence (6) 6
acute lymphatic leukemia (5) 5
age (5) 5
all (5) 5
antimetabolites, antineoplastic - administration & dosage (5) 5
chromosome aberrations (5) 5
doxorubicin (5) 5
expression (5) 5
genes (5) 5
genetic aspects (5) 5
karyotyping (5) 5
minimal residual disease (5) 5
prednisolone (5) 5
treatment outcome (5) 5
adolescents (4) 4
analysis (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
childhood acute lymphoblastic leukaemia (4) 4
chromosomes (4) 4
classification (4) 4
cytogenetics (4) 4
diagnosis (4) 4
dna methylation (4) 4
drug therapy (4) 4
flow cytometry (4) 4
hemic and lymphatic diseases (4) 4
in vitro drug resistance (4) 4
leucovorin (4) 4
leukemia, myeloid, acute - mortality (4) 4
leukemia, myeloid, acute - pathology (4) 4
mutation (4) 4
notch1 (4) 4
oncogene proteins, fusion - genetics (4) 4
pediatric-oncology-group (4) 4
pharmacokinetics (4) 4
preschool (4) 4
research (4) 4
rq-pcr (4) 4
scandinavian and nordic countries (4) 4
stem-cell transplantation (4) 4
t (4) 4
therapy (4) 4
abnormalities (3) 3
acute lymphocytic-leukemia (3) 3
adult (3) 3
age factors (3) 3
aml (3) 3
antimetabolites, antineoplastic - adverse effects (3) 3
antineoplastic combined chemotherapy protocols (3) 3
biochemistry & molecular biology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Genetics, ISSN 1061-4036, 04/2015, Volume 47, Issue 4, pp. 330 - 337
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2011, Volume 29, Issue 3, pp. 310 - 315
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2010, Volume 107, Issue 50, pp. 21719 - 21724
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e65373
Background: Treatment of pediatric T-cell acute lymphoblastic leukemia (T-ALL) has improved, but there is a considerable fraction of patients experiencing a... 
THERAPY | NOTCH1 | GENE | MULTIDISCIPLINARY SCIENCES | PHENOTYPE | PROTEINS | POLYCOMB | CANCER | EXPRESSION | LINES | Multivariate Analysis | Promoter Regions, Genetic | Genome-Wide Association Study | Prognosis | Humans | Child, Preschool | Infant | Male | Gene Expression Profiling | Gene Expression Regulation, Leukemic | Neoplasm Proteins - metabolism | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - mortality | DNA Methylation | Phenotype | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Adolescent | Survival Analysis | CpG Islands | Female | Genome, Human | Neoplasm Proteins - genetics | Child | Pediatrics | Genes | DNA binding proteins | Genetic transcription | T cells | DNA | Genetic aspects | Acute lymphocytic leukemia | Comparative analysis | Methylation | Blood cell count | Cancer | Cell culture | Transcription factors | Target recognition | Leukemia | Genomics | Genomes | Lymphocytes T | Multivariate analysis | Kinases | Subgroups | DNA methylation | Bone marrow | Children | Deoxyribonucleic acid--DNA | CpG islands | Cell survival | Acute lymphatic leukemia | Hematology | Lymphatic leukemia | Gene expression | Patients | Survival | White blood cells | Studies | Polycomb group proteins | Pathology | Medical prognosis | Epigenetics | Aberration | Medical and Health Sciences | Medicin och hälsovetenskap | Deoxyribonucleic acid
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 07/2017, Volume 64, Issue 7, p. n/a
Background Carboxypeptidase G2 (CPDG2) can be used as rescue treatment in cases of delayed methotrexate elimination (DME) and Mtx‐induced nephrotoxicity.... 
ALL | delayed methotrexate elimination | children | glucarpidase | CLEARANCE | LEUCOVORIN | RENAL DYSFUNCTION | CANCER-PATIENTS | THERAPY | RESCUE | PHARMACOKINETICS | ONCOLOGY | PEDIATRICS | HEMATOLOGY | INTERVENTION | NEPHROTOXICITY | Kidney - drug effects | Humans | Child, Preschool | Infant | Male | Methotrexate - blood | Acute Kidney Injury - prevention & control | Antimetabolites, Antineoplastic - administration & dosage | Kidney Function Tests | Methotrexate - adverse effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Antimetabolites, Antineoplastic - blood | gamma-Glutamyl Hydrolase - therapeutic use | Adolescent | Antimetabolites, Antineoplastic - adverse effects | Female | Methotrexate - administration & dosage | Acute Kidney Injury - chemically induced | Child | Pediatrics | Usage | Care and treatment | Dosage and administration | Acute lymphocytic leukemia | Children | Methotrexate | Drug therapy | Health aspects | High performance liquid chromatography | Cancer | Creatinine | Correlation | Renal function | Acute lymphatic leukemia | Hematology | Leukemia | Immune clearance | Liquid chromatography | Carboxypeptidase | Time measurement | Lymphatic leukemia | High-performance liquid chromatography | Patients | Philadelphia chromosome | Infusion | Measurement methods | Plasma levels | Surface area | Kidney transplantation | Index Medicus | Pediatrik
Journal Article
Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 5, pp. 978 - 984
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 1/2015, Volume 75, Issue 1, pp. 59 - 66
Through enhancement of 6-mercaptopurine (6MP) bioavailability and inhibition of purine de novo synthesis, high-dose methotrexate (HD-MTX) may increase... 
Chemotherapy | Medicine & Public Health | Toxicity | Oncology | Cancer Research | Pharmacology/Toxicology | Pediatric | TRIALS | MAINTENANCE CHEMOTHERAPY | NOPHO ALL-92 | RISK | CHILDREN | RELAPSE | THERAPY | ACUTE LYMPHOBLASTIC-LEUKEMIA | PHARMACOLOGY & PHARMACY | DOSAGE | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Follow-Up Studies | Humans | Methyltransferases - metabolism | Methyltransferases - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Male | Risk | Methotrexate - therapeutic use | Antimetabolites, Antineoplastic - administration & dosage | Dose-Response Relationship, Drug | Maintenance Chemotherapy - adverse effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Mercaptopurine - therapeutic use | Leukopenia - chemically induced | Female | Retrospective Studies | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Child | Myelopoiesis - drug effects | Scandinavian and Nordic Countries - epidemiology | Nucleic Acid Synthesis Inhibitors - therapeutic use | Nucleic Acid Synthesis Inhibitors - adverse effects | Nucleic Acid Synthesis Inhibitors - administration & dosage | Mercaptopurine - administration & dosage | Mercaptopurine - adverse effects | Leukopenia - epidemiology | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Precursor Cell Lymphoblastic Leukemia-Lymphoma - enzymology | Heterozygote | Methotrexate - administration & dosage | Metabolites | Analysis | Transferases | Dosage and administration | Nucleotides | Methotrexate | Mercaptopurine | Cancer | Index Medicus | Clinical Medicine | Pediatrics | Medical and Health Sciences | Medicin och hälsovetenskap | Pediatrik | Klinisk medicin
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2005, Volume 128, Issue 6, pp. 797 - 804
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 03/2014, Volume 61, Issue 3, pp. 424 - 430
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 01/2016, Volume 63, Issue 1, pp. 83 - 92
Journal Article